SECCHI, MASSIMILIANO
 Distribuzione geografica
Continente #
AS - Asia 166
NA - Nord America 162
EU - Europa 159
SA - Sud America 26
AF - Africa 1
OC - Oceania 1
Totale 515
Nazione #
US - Stati Uniti d'America 152
IE - Irlanda 68
SG - Singapore 53
HK - Hong Kong 50
CN - Cina 46
RU - Federazione Russa 36
IT - Italia 32
BR - Brasile 22
GB - Regno Unito 8
CA - Canada 6
VN - Vietnam 6
DE - Germania 5
EC - Ecuador 3
IN - India 3
MX - Messico 3
ES - Italia 2
FI - Finlandia 2
IQ - Iraq 2
NL - Olanda 2
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
JO - Giordania 1
JP - Giappone 1
NP - Nepal 1
PL - Polonia 1
RS - Serbia 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
VC - Saint Vincent e Grenadine 1
Totale 515
Città #
Dublin 68
Dallas 60
Hong Kong 50
Singapore 26
Ashburn 22
Beijing 16
Boardman 12
Milan 11
Los Angeles 8
Shanghai 8
Moscow 6
Imbersago 5
Lissone 5
Florence 4
Montreal 4
São Paulo 4
The Dalles 4
Boston 3
Buffalo 3
Ho Chi Minh City 3
New York 3
Redondo Beach 3
Rio de Janeiro 3
Santa Clara 3
Denver 2
Helsinki 2
Mainz 2
Mexico City 2
Orem 2
Phoenix 2
Poplar 2
Secaucus 2
Washington 2
Acapulco de Juárez 1
Ambato 1
Amman 1
Amsterdam 1
Ankara 1
Apopka 1
Aryanah 1
Baghdad 1
Barnaul 1
Belgrade 1
Bismarck 1
Bologna 1
Brooklyn 1
Buenos Aires 1
Campo Grande 1
Candelária 1
Chennai 1
Contagem 1
Cuiabá 1
Delhi 1
Dhaka 1
Dongguan 1
Erbil 1
Guangzhou 1
Haiphong 1
Hangzhou 1
Hanoi 1
Hefei 1
Itatinga 1
Jitaúna 1
Kathmandu 1
Kingstown 1
Langfang 1
Lorca 1
McDonough 1
Montenegro 1
Natal 1
New Delhi 1
Ninh Bình 1
Nova Serrana 1
Nuremberg 1
Pedro Carbo 1
Quito 1
Rome 1
Salvador 1
Saskatoon 1
Senador Canedo 1
Smolyan 1
Sumaré 1
São Bernardo do Campo 1
São João da Boa Vista 1
São Mateus 1
Tashkent 1
Tianjin 1
Tokyo 1
Utica 1
Warsaw 1
Weihai 1
Zunyi 1
Totale 411
Nome #
Combination of the CCL5-derived peptide R4.0 with different HIV-1 blockers reveals wide target compatibility and synergic cobinding to CCR5 65
Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops 50
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 44
Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses 43
Editorial: CCR5: A receptor at the center stage in infection 43
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides 42
Rational Engineering of a Sub-Picomolar HIV-1 Blocker 40
Rational CCL5 mutagenesis integration in a lactobacilli platform generates extremely potent HIV-1 blockers 38
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 35
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 33
Modified microbiota for microbicide drug delivery 33
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 31
Synergistic action of human RNaseH2 and the RNA helicase-nuclease DDX3X in processing R-loops 29
null 5
Totale 531
Categoria #
all - tutte 3.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202377 0 0 0 0 0 0 0 0 76 1 0 0
2023/202436 2 1 2 7 4 7 1 4 1 2 3 2
2024/2025183 1 11 0 2 3 12 3 29 46 9 25 42
2025/2026235 29 43 80 27 56 0 0 0 0 0 0 0
Totale 531